Economizing with psychotropic drugs.
Every health practitioner can reduce the cost of his treatments without compromising their quality. A review of the magnitude of the cost problem with regard to psychotropic drugs, variables which affect cost, the methods by which the clinician can manipulate the variables to reduce costs, and the application of these methods to the major classes of psychotropic drugs will show that substantial savings can be achieved easily and with no sacrifice in efficacy.
D014151:Anti-Anxiety Agents / Q000008:administration & dosage; D000928:Antidepressive Agents / Q000008:administration & dosage; D003365:Costs and Cost Analysis; D005252:Fees, Pharmaceutical; D006801:Humans; D011306:Prescription Fees; D011618:Psychotic Disorders / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000008:administration & dosage*; D014481:United States
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D011619:Psychotropic Drugs